News articles about Analogic (NASDAQ:ALOG) have trended somewhat positive on Thursday, Accern reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Analogic earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave news headlines about the medical research company an impact score of 47.0604086613571 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Several brokerages have recently issued reports on ALOG. BidaskClub lowered shares of Analogic from a “sell” rating to a “strong sell” rating in a research note on Saturday, January 6th. Jefferies Group restated a “hold” rating and set a $80.00 price target on shares of Analogic in a research note on Friday, December 8th. Finally, Zacks Investment Research raised shares of Analogic from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a report on Friday, December 8th.
Analogic (NASDAQ:ALOG) opened at $84.80 on Thursday. The company has a market cap of $1,048.09, a P/E ratio of -14.83, a P/E/G ratio of 4.19 and a beta of 0.86. Analogic has a fifty-two week low of $66.00 and a fifty-two week high of $89.50.
Analogic (NASDAQ:ALOG) last released its quarterly earnings data on Wednesday, December 6th. The medical research company reported $0.75 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.43 by $0.32. The company had revenue of $106.90 million during the quarter, compared to the consensus estimate of $100.55 million. Analogic had a negative net margin of 15.06% and a positive return on equity of 5.09%. Analogic’s revenue for the quarter was down 11.7% on a year-over-year basis. During the same period last year, the firm earned $0.43 EPS. equities analysts predict that Analogic will post 2.86 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 29th. Investors of record on Friday, December 15th were issued a $0.10 dividend. This represents a $0.40 annualized dividend and a yield of 0.47%. The ex-dividend date was Thursday, December 14th. Analogic’s dividend payout ratio (DPR) is presently -6.99%.
WARNING: “Analogic (NASDAQ:ALOG) Receives Daily Media Sentiment Rating of 0.19” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/18/analogic-alog-given-media-impact-score-of-0-19.html.
Analogic Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.